Dr. Jordi Sierra, director of the Sant Pau Haematology Service and head of the Oncological Haematology and Transplantation Group at the Sant Pau Research Institute, is one of the driving forces behind the RET-A project ‘Strategic Reflection on the Management and Implementation of New Advanced Therapies’, a pioneering initiative in Spain that will be the first think tank ‘(ideas laboratory) to deepen, analyse and expose the challenges and opportunities of new cell therapies.
This analysis will try to answer four key questions: what is the starting map, what would be the desired comprehensive care process, what are the innovative models of economic evaluation to apply and what is the future of these therapies. At its first meeting, the CORE Advisory Group, in which the Sociedad Española de Directivos de la Salud (SEDISA) participates, among others, met to propose the most appropriate framework, design and scope of the project, on which the technical working groups will subsequently work.
This driving group is made up of, in addition to Dr. Jordi Sierra, for the president of the Sociedad Española de Farmacia Hospitalaria (SEFH), Dr. Miguel Ángel Calleja; the director of the Hematology Service of the Hospital General Universitario Gregorio Marañón in Madrid, Dr. José Luis Díez; the president of SEDISA, Joaquín Estévez; Doctor Ramón García Sanz, haematologist at the University Hospital of Salamanca and elected president of the Spanish Society of Haematology and Haemotherapy (SEHH); the director of the Haematology Service at the University Hospital 12 de Octubre in Madrid, Doctor Joaquín Martínez and the president of the Spanish Society of Medical Oncology (SEOM), Doctor Ruth Vera.
